Interventional procedure overview of endoluminal gastroplication for gastro-oesophageal reflux disease
Closed for comments This consultation ended on at Request commenting lead permission
Validity and generalisability of the studies
Most of the evidence relates to the Esophyx device, with studies utilising the MUSE and GORDx devices also included in the key evidence.
Follow up for studies ranged between 12 months and 10 years (but with high loss to follow up for studies with longer follow up periods).
Some of the included studies have used previous versions of a device which are no longer available for use.
How are you taking part in this consultation?
You will not be able to change how you comment later.
You must be signed in to answer questions